Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?-Reference-Cited by-同舟云学术

Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?

Published:2015-04-03 Issue:6 Volume:20 Page:1072-1080
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Maeda Hideki,Kurokawa Tatsuo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-015-0825-4.pdf

Reference31 articles.

1. Gunjan S (2010) Japan works to shorten drug lag boost trials of new drugs. J Natl Cancer Inst 102:148–150

2. Tsuji K, Tsutani K (2008) If Japan is to become a front-runner in pharmaceutical development, it must not only speed up its approval of new drugs, but also enhance its own research capabilities. Nature 32:851–852

3. Yonemori K, Hirakawa A, Ando M et al (2011) The notorious “drug lag” for oncology drugs in Japan. Invest New Drugs 29:706–712

4. Mendelsohn J (2013) Personalizing oncology: perspective and prospects. J Clin Oncol 31:1904–1911

5. Ministry of Health, Labour and Welfare (2005) The revision of the guideline for clinical evaluation methods of anticancer drugs in Japan. http://home.att.ne.jp/red/akihiro/anticancer/MHLW_gl_notice.pdf . Accessed Nov 2014 (in Japanese)

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Qualitative Interview Study on Expanded Access Clinical Trials for Compassionate Use in Japan;Patient Preference and Adherence;2024-07

2. Assessing drug lag in new drug approvals by the Iran Food and Drug Administration compared to the U.S. FDA, EMA, and PMDA: A 20-year analysis (2001–2021);Medicine;2024-06-21

3. Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology;Therapeutic Innovation & Regulatory Science;2024-04-23

4. Trends in oncology drug lags in Japan from 2001 to 2020: A cross‐sectional study;Clinical and Translational Science;2023-10-17

5. Comparison of the Speed of Enrollment for Clinical Trials Conducted by Japanese and Global Pharmaceutical Companies;Biological and Pharmaceutical Bulletin;2023-09-01